Metabolic signature of obesity-associated insulin resistance and type 2 diabetes.
Haya Al-SulaitiIlhame DibounMaha V AghaFatima F S MohamedStephen AtkinAlex S DömlingMohamed A ElrayessNayef A MazloumPublished in: Journal of translational medicine (2019)
This pilot data has identified phospholipid metabolites as potential novel biomarkers of obesity-associated insulin sensitivity and confirmed the association of known metabolites with increased risk of obesity-associated insulin resistance, with possible diagnostic and therapeutic applications. Further studies are warranted to confirm these associations in prospective cohorts and to investigate their functionality.